Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transplantation, Heterologous | 24 | 2004 | 2382 | 1.490 |
Why?
|
Graft Rejection | 51 | 2011 | 4397 | 1.230 |
Why?
|
Tracheostomy | 2 | 2021 | 401 | 1.160 |
Why?
|
Skin Transplantation | 27 | 2011 | 1074 | 1.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5221 | 0.940 |
Why?
|
Transplantation Immunology | 10 | 2004 | 546 | 0.860 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2023 | 153 | 0.790 |
Why?
|
Pericardial Effusion | 1 | 2023 | 247 | 0.780 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2021 | 85 | 0.690 |
Why?
|
Pleural Neoplasms | 1 | 2023 | 607 | 0.640 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13102 | 0.630 |
Why?
|
Histocompatibility Antigens Class II | 16 | 2002 | 1475 | 0.620 |
Why?
|
Radiosurgery | 2 | 2024 | 1329 | 0.600 |
Why?
|
Graft Survival | 32 | 2011 | 3737 | 0.580 |
Why?
|
Islets of Langerhans Transplantation | 12 | 2008 | 745 | 0.580 |
Why?
|
Immune Tolerance | 16 | 2010 | 2258 | 0.580 |
Why?
|
CD4-Positive T-Lymphocytes | 17 | 2005 | 4386 | 0.510 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 9 | 1992 | 906 | 0.500 |
Why?
|
T-Lymphocytes | 23 | 2011 | 10180 | 0.490 |
Why?
|
Lymphocyte Depletion | 9 | 2004 | 608 | 0.430 |
Why?
|
Allergy and Immunology | 2 | 2011 | 169 | 0.420 |
Why?
|
Tracheal Diseases | 1 | 2012 | 113 | 0.410 |
Why?
|
Vascular Surgical Procedures | 1 | 2021 | 1475 | 0.410 |
Why?
|
Thoracic Surgical Procedures | 1 | 2015 | 342 | 0.400 |
Why?
|
Heart Transplantation | 14 | 2011 | 3110 | 0.390 |
Why?
|
Lymphatic Diseases | 1 | 2012 | 324 | 0.380 |
Why?
|
Histocompatibility Antigens Class I | 8 | 1999 | 1366 | 0.370 |
Why?
|
T-Lymphocytes, Helper-Inducer | 7 | 1997 | 986 | 0.370 |
Why?
|
Lymphocyte Activation | 9 | 2011 | 5524 | 0.360 |
Why?
|
Mice, Inbred BALB C | 34 | 2011 | 6386 | 0.350 |
Why?
|
Cell Transplantation | 6 | 2000 | 477 | 0.340 |
Why?
|
Isoantigens | 6 | 2001 | 567 | 0.340 |
Why?
|
Transplantation Tolerance | 3 | 2004 | 617 | 0.320 |
Why?
|
Organ Transplantation | 4 | 1999 | 1139 | 0.310 |
Why?
|
Diabetes Mellitus, Type 1 | 15 | 2008 | 3336 | 0.300 |
Why?
|
Transplantation, Homologous | 19 | 2011 | 4776 | 0.290 |
Why?
|
Trachea | 1 | 2012 | 1076 | 0.290 |
Why?
|
Major Histocompatibility Complex | 6 | 2001 | 936 | 0.280 |
Why?
|
Isoantibodies | 8 | 2006 | 679 | 0.270 |
Why?
|
Genes, MHC Class II | 5 | 2004 | 457 | 0.260 |
Why?
|
Antigen Presentation | 4 | 2004 | 1284 | 0.250 |
Why?
|
Disease Management | 1 | 2015 | 2459 | 0.250 |
Why?
|
Graft Enhancement, Immunologic | 3 | 2004 | 59 | 0.240 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2002 | 0.240 |
Why?
|
Animals | 91 | 2011 | 168757 | 0.240 |
Why?
|
Antibodies, Monoclonal | 20 | 2005 | 9274 | 0.230 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11031 | 0.230 |
Why?
|
Immunoconjugates | 3 | 2001 | 901 | 0.230 |
Why?
|
Kaplan-Meier Estimate | 2 | 2024 | 6538 | 0.220 |
Why?
|
Immunosuppressive Agents | 10 | 2006 | 4149 | 0.220 |
Why?
|
Antigens, Differentiation | 5 | 2005 | 927 | 0.220 |
Why?
|
Cyclosporins | 4 | 1990 | 220 | 0.210 |
Why?
|
Pneumonectomy | 3 | 2023 | 1094 | 0.210 |
Why?
|
Antigens, Surface | 4 | 2003 | 1663 | 0.210 |
Why?
|
Nuclear Transfer Techniques | 1 | 2002 | 64 | 0.210 |
Why?
|
Bronchoscopy | 2 | 2021 | 862 | 0.210 |
Why?
|
Mice, Inbred C57BL | 34 | 2007 | 21827 | 0.200 |
Why?
|
Kidney Transplantation | 18 | 2004 | 4251 | 0.200 |
Why?
|
Mice | 63 | 2011 | 81183 | 0.200 |
Why?
|
Subclavian Vein | 1 | 2021 | 54 | 0.200 |
Why?
|
Mice, Mutant Strains | 11 | 2005 | 1866 | 0.190 |
Why?
|
T-Lymphocyte Subsets | 5 | 2003 | 1838 | 0.190 |
Why?
|
Subclavian Artery | 1 | 2021 | 130 | 0.180 |
Why?
|
Antigen-Presenting Cells | 7 | 2001 | 973 | 0.180 |
Why?
|
Antilymphocyte Serum | 7 | 2003 | 492 | 0.180 |
Why?
|
Lymphocyte Cooperation | 2 | 1996 | 112 | 0.180 |
Why?
|
Dilatation | 1 | 2021 | 291 | 0.180 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2657 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 10 | 2005 | 4479 | 0.170 |
Why?
|
Insurance Coverage | 3 | 2016 | 1901 | 0.170 |
Why?
|
Ribs | 1 | 2021 | 252 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2001 | 595 | 0.170 |
Why?
|
Mice, Inbred Strains | 10 | 2002 | 1827 | 0.170 |
Why?
|
Brachial Plexus | 1 | 2021 | 163 | 0.170 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2002 | 555 | 0.170 |
Why?
|
Clavicle | 1 | 2021 | 209 | 0.170 |
Why?
|
Immunity, Cellular | 5 | 1999 | 1607 | 0.160 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2023 | 388 | 0.160 |
Why?
|
Histocompatibility Antigens | 5 | 1996 | 471 | 0.160 |
Why?
|
Autoimmunity | 4 | 2007 | 1349 | 0.150 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2005 | 1821 | 0.150 |
Why?
|
Thorax | 1 | 2021 | 547 | 0.150 |
Why?
|
Humans | 76 | 2024 | 744343 | 0.150 |
Why?
|
Swine | 14 | 2004 | 5917 | 0.150 |
Why?
|
Genes, MHC Class I | 3 | 1997 | 258 | 0.150 |
Why?
|
Health Care Reform | 3 | 2016 | 1261 | 0.140 |
Why?
|
CD40 Ligand | 5 | 2006 | 526 | 0.140 |
Why?
|
Pancreas Transplantation | 7 | 2003 | 187 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2021 | 451 | 0.140 |
Why?
|
History, 20th Century | 4 | 2011 | 2740 | 0.130 |
Why?
|
Healthcare Disparities | 3 | 2016 | 3158 | 0.130 |
Why?
|
Spleen | 5 | 2004 | 2362 | 0.130 |
Why?
|
Cholecystitis, Acute | 1 | 2015 | 70 | 0.130 |
Why?
|
Host vs Graft Reaction | 1 | 1994 | 14 | 0.120 |
Why?
|
Insurance, Health | 3 | 2016 | 2494 | 0.120 |
Why?
|
Aftercare | 1 | 2020 | 866 | 0.120 |
Why?
|
Bone Marrow Transplantation | 7 | 2001 | 2765 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.120 |
Why?
|
Mice, Inbred NOD | 8 | 2008 | 1878 | 0.120 |
Why?
|
Antigens, CD | 9 | 2005 | 4026 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 6 | 1993 | 1369 | 0.120 |
Why?
|
Swine, Miniature | 7 | 2004 | 961 | 0.120 |
Why?
|
Myocytes, Cardiac | 1 | 2002 | 1637 | 0.110 |
Why?
|
Resource Allocation | 2 | 1994 | 341 | 0.110 |
Why?
|
Streptozocin | 2 | 2003 | 196 | 0.110 |
Why?
|
Radiation Chimera | 3 | 1988 | 223 | 0.110 |
Why?
|
Cholecystectomy | 1 | 2015 | 395 | 0.110 |
Why?
|
Receptors, Chemokine | 3 | 2006 | 669 | 0.110 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 1996 | 307 | 0.110 |
Why?
|
Thymectomy | 5 | 1994 | 191 | 0.110 |
Why?
|
Cyclosporine | 5 | 2004 | 786 | 0.110 |
Why?
|
Thoracic Surgery | 1 | 2019 | 719 | 0.110 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2003 | 1116 | 0.100 |
Why?
|
Tissue Engineering | 1 | 2002 | 1880 | 0.100 |
Why?
|
Antigens, Heterophile | 1 | 1992 | 69 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 1999 | 1584 | 0.100 |
Why?
|
Islets of Langerhans | 4 | 2008 | 1352 | 0.100 |
Why?
|
Macaca fascicularis | 6 | 2006 | 915 | 0.100 |
Why?
|
Research | 1 | 1999 | 1999 | 0.100 |
Why?
|
Liver Transplantation | 5 | 1996 | 2119 | 0.090 |
Why?
|
Species Specificity | 8 | 2002 | 2478 | 0.090 |
Why?
|
Tissue Donors | 6 | 2004 | 2240 | 0.090 |
Why?
|
Immunoglobulin Idiotypes | 4 | 1983 | 201 | 0.090 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 381 | 0.090 |
Why?
|
Comorbidity | 1 | 2024 | 10388 | 0.090 |
Why?
|
Models, Immunological | 4 | 2002 | 527 | 0.080 |
Why?
|
Antibodies | 5 | 2007 | 2460 | 0.080 |
Why?
|
Health Care Rationing | 1 | 1992 | 437 | 0.080 |
Why?
|
Bioethics | 2 | 2000 | 116 | 0.080 |
Why?
|
Government Programs | 1 | 2010 | 275 | 0.080 |
Why?
|
Mice, Inbred C3H | 5 | 1993 | 964 | 0.080 |
Why?
|
Immune System Diseases | 1 | 2010 | 262 | 0.080 |
Why?
|
Mice, Inbred A | 4 | 1998 | 248 | 0.080 |
Why?
|
Adoptive Transfer | 4 | 2005 | 844 | 0.080 |
Why?
|
Ethics, Medical | 3 | 2000 | 792 | 0.080 |
Why?
|
Antibodies, Anti-Idiotypic | 4 | 1983 | 349 | 0.080 |
Why?
|
alpha 1-Antitrypsin | 1 | 2008 | 164 | 0.080 |
Why?
|
Histocompatibility Testing | 5 | 2002 | 741 | 0.070 |
Why?
|
Health Status Disparities | 2 | 2016 | 1797 | 0.070 |
Why?
|
Mice, Knockout | 10 | 2011 | 14557 | 0.070 |
Why?
|
Transplantation | 2 | 2004 | 217 | 0.070 |
Why?
|
Integrin beta3 | 1 | 2007 | 122 | 0.070 |
Why?
|
Zoonoses | 2 | 2000 | 185 | 0.070 |
Why?
|
Th2 Cells | 4 | 2011 | 1061 | 0.070 |
Why?
|
Primates | 2 | 1999 | 545 | 0.070 |
Why?
|
Crosses, Genetic | 4 | 1995 | 791 | 0.070 |
Why?
|
Autoantigens | 2 | 2002 | 892 | 0.070 |
Why?
|
Th1 Cells | 4 | 2011 | 1057 | 0.070 |
Why?
|
Interleukin-2 | 2 | 2007 | 1904 | 0.070 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1209 | 0.070 |
Why?
|
Cytokines | 7 | 2007 | 7322 | 0.070 |
Why?
|
Budgets | 1 | 2007 | 229 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.060 |
Why?
|
H-2 Antigens | 3 | 1998 | 366 | 0.060 |
Why?
|
Transplantation, Heterotopic | 1 | 2005 | 175 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2004 | 2988 | 0.060 |
Why?
|
Massachusetts | 5 | 2019 | 8663 | 0.060 |
Why?
|
Fetal Tissue Transplantation | 1 | 2004 | 139 | 0.060 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2004 | 48 | 0.060 |
Why?
|
Insulin-Secreting Cells | 2 | 2008 | 891 | 0.060 |
Why?
|
Bone Marrow | 3 | 1993 | 2948 | 0.060 |
Why?
|
B-Lymphocytes | 2 | 1996 | 4665 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3537 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2023 | 77449 | 0.060 |
Why?
|
C-Peptide | 4 | 2008 | 419 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4687 | 0.060 |
Why?
|
beta 2-Microglobulin | 2 | 1995 | 315 | 0.060 |
Why?
|
Immunologic Memory | 3 | 2005 | 1348 | 0.050 |
Why?
|
Prognosis | 1 | 2023 | 29063 | 0.050 |
Why?
|
Cloning, Organism | 1 | 2002 | 54 | 0.050 |
Why?
|
Self Tolerance | 1 | 2002 | 125 | 0.050 |
Why?
|
Male | 36 | 2021 | 350118 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2016 | 5137 | 0.050 |
Why?
|
Rabbits | 6 | 1991 | 4894 | 0.050 |
Why?
|
Cell Adhesion Molecules | 3 | 1993 | 1602 | 0.050 |
Why?
|
Mice, SCID | 2 | 1998 | 2716 | 0.050 |
Why?
|
Mice, Transgenic | 5 | 2007 | 9734 | 0.050 |
Why?
|
History, 19th Century | 1 | 2004 | 720 | 0.050 |
Why?
|
Thymus Gland | 4 | 2001 | 1267 | 0.050 |
Why?
|
Polyglycolic Acid | 1 | 2002 | 407 | 0.050 |
Why?
|
Patient Selection | 2 | 1994 | 4215 | 0.050 |
Why?
|
Down-Regulation | 2 | 2005 | 3002 | 0.050 |
Why?
|
Kidney | 6 | 2003 | 7186 | 0.050 |
Why?
|
Acute Disease | 6 | 2005 | 7149 | 0.050 |
Why?
|
Tacrolimus | 1 | 2004 | 743 | 0.050 |
Why?
|
Coated Materials, Biocompatible | 1 | 2002 | 319 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2002 | 497 | 0.050 |
Why?
|
Intraoperative Care | 1 | 2003 | 767 | 0.040 |
Why?
|
Health Policy | 1 | 1992 | 2661 | 0.040 |
Why?
|
Killer Cells, Natural | 3 | 2005 | 2133 | 0.040 |
Why?
|
Tissue and Organ Procurement | 4 | 1994 | 896 | 0.040 |
Why?
|
Antibodies, Blocking | 3 | 2005 | 253 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1026 | 0.040 |
Why?
|
Transplantation Chimera | 2 | 1999 | 612 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15540 | 0.040 |
Why?
|
Clone Cells | 1 | 2002 | 1692 | 0.040 |
Why?
|
Membrane Glycoproteins | 4 | 2005 | 3768 | 0.040 |
Why?
|
Retroviridae Infections | 1 | 1999 | 151 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5788 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 2002 | 517 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2000 | 343 | 0.040 |
Why?
|
Epitopes | 3 | 1995 | 2571 | 0.040 |
Why?
|
Female | 34 | 2021 | 380194 | 0.040 |
Why?
|
Legislation, Medical | 1 | 1998 | 100 | 0.040 |
Why?
|
Genes | 1 | 1981 | 1893 | 0.040 |
Why?
|
Steroids | 2 | 2000 | 930 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12959 | 0.040 |
Why?
|
Immunoglobulin G | 5 | 2000 | 4560 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2002 | 2124 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2001 | 19229 | 0.040 |
Why?
|
Insulin | 6 | 2008 | 6580 | 0.040 |
Why?
|
Gene Transfer Techniques | 1 | 2002 | 1224 | 0.040 |
Why?
|
Postoperative Care | 1 | 2003 | 1486 | 0.040 |
Why?
|
Portacaval Shunt, Surgical | 1 | 1996 | 49 | 0.040 |
Why?
|
Hospitals, General | 1 | 2001 | 749 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2005 | 7880 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 1998 | 3772 | 0.030 |
Why?
|
Signal Transduction | 5 | 2008 | 23403 | 0.030 |
Why?
|
Cattle | 1 | 2002 | 3922 | 0.030 |
Why?
|
Solubility | 1 | 1998 | 1085 | 0.030 |
Why?
|
Genetic Linkage | 1 | 1981 | 2421 | 0.030 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 279 | 0.030 |
Why?
|
Antigens | 1 | 1981 | 1466 | 0.030 |
Why?
|
Kidney Diseases | 2 | 2006 | 2149 | 0.030 |
Why?
|
Muromonab-CD3 | 2 | 1994 | 96 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 1998 | 357 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2029 | 0.030 |
Why?
|
Models, Animal | 1 | 2002 | 2171 | 0.030 |
Why?
|
Flow Cytometry | 4 | 1996 | 5974 | 0.030 |
Why?
|
Retroviridae | 1 | 1998 | 914 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2010 | 7913 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2010 | 780 | 0.030 |
Why?
|
Tissue Survival | 1 | 1995 | 118 | 0.030 |
Why?
|
Portal Vein | 2 | 2008 | 437 | 0.030 |
Why?
|
Cell Movement | 1 | 2007 | 5217 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3479 | 0.030 |
Why?
|
Middle Aged | 17 | 2021 | 213383 | 0.030 |
Why?
|
Boston | 3 | 2004 | 9313 | 0.030 |
Why?
|
Adult | 24 | 2019 | 214055 | 0.030 |
Why?
|
Clonal Deletion | 1 | 1994 | 79 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 1995 | 315 | 0.030 |
Why?
|
Time Factors | 9 | 2008 | 40075 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2008 | 11483 | 0.030 |
Why?
|
Pancreas | 3 | 2006 | 1686 | 0.030 |
Why?
|
Rodentia | 1 | 1995 | 261 | 0.030 |
Why?
|
Clonal Anergy | 1 | 1994 | 169 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 1981 | 4740 | 0.030 |
Why?
|
Mastectomy, Radical | 2 | 1965 | 20 | 0.030 |
Why?
|
Immunoglobulin M | 3 | 1989 | 1537 | 0.030 |
Why?
|
Transplantation, Isogeneic | 2 | 2002 | 257 | 0.030 |
Why?
|
Hepatitis C | 1 | 2003 | 1591 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57776 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2016 | 594 | 0.030 |
Why?
|
Models, Biological | 2 | 2002 | 9583 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2003 | 63114 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1995 | 560 | 0.030 |
Why?
|
Antigen-Antibody Reactions | 2 | 1982 | 363 | 0.030 |
Why?
|
Rats, Inbred WKY | 1 | 1991 | 158 | 0.030 |
Why?
|
Rats, Inbred SHR | 1 | 1991 | 195 | 0.030 |
Why?
|
Glucose Tolerance Test | 2 | 2006 | 1150 | 0.020 |
Why?
|
Haplotypes | 1 | 1998 | 2779 | 0.020 |
Why?
|
Cadaver | 4 | 2003 | 1337 | 0.020 |
Why?
|
Biomedical Research | 1 | 2007 | 3309 | 0.020 |
Why?
|
United States | 5 | 2023 | 69872 | 0.020 |
Why?
|
Inflammation | 2 | 2008 | 10638 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8642 | 0.020 |
Why?
|
Haplorhini | 1 | 1991 | 552 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 2133 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 1993 | 1155 | 0.020 |
Why?
|
Federal Government | 1 | 1992 | 260 | 0.020 |
Why?
|
Life Support Care | 1 | 1992 | 228 | 0.020 |
Why?
|
Health Planning | 1 | 1992 | 238 | 0.020 |
Why?
|
Ciprofloxacin | 1 | 1992 | 315 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2003 | 2987 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2001 | 4420 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6314 | 0.020 |
Why?
|
Transfection | 1 | 1998 | 5892 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1989 | 370 | 0.020 |
Why?
|
Fluconazole | 1 | 1989 | 146 | 0.020 |
Why?
|
Sirolimus | 2 | 2007 | 1564 | 0.020 |
Why?
|
Reoperation | 3 | 1996 | 4201 | 0.020 |
Why?
|
New England | 1 | 1992 | 1022 | 0.020 |
Why?
|
Gene Expression | 1 | 2002 | 7799 | 0.020 |
Why?
|
Chemokines | 2 | 2004 | 970 | 0.020 |
Why?
|
Aged | 6 | 2022 | 163280 | 0.020 |
Why?
|
Lymphokines | 1 | 1992 | 949 | 0.020 |
Why?
|
Urinary Tract Infections | 2 | 1992 | 788 | 0.020 |
Why?
|
Autopsy | 2 | 2008 | 1020 | 0.020 |
Why?
|
Antibody Formation | 2 | 1991 | 1402 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12354 | 0.020 |
Why?
|
Skin | 2 | 1994 | 4364 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2011 | 1147 | 0.020 |
Why?
|
Waiting Lists | 1 | 1992 | 692 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1992 | 732 | 0.020 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39050 | 0.020 |
Why?
|
Integrin alpha4beta1 | 1 | 2007 | 121 | 0.020 |
Why?
|
Interleukin-15 | 1 | 2007 | 184 | 0.020 |
Why?
|
Blood Glucose | 4 | 2006 | 6256 | 0.020 |
Why?
|
Kidney Pelvis | 1 | 1987 | 188 | 0.020 |
Why?
|
Mycoses | 1 | 1989 | 376 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2013 | 2453 | 0.020 |
Why?
|
Creatinine | 4 | 1996 | 1919 | 0.020 |
Why?
|
Binding Sites, Antibody | 2 | 1983 | 349 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5952 | 0.020 |
Why?
|
Prospective Studies | 4 | 2021 | 53288 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 378 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1992 | 1423 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2008 | 3474 | 0.020 |
Why?
|
Sutures | 1 | 1987 | 299 | 0.020 |
Why?
|
Azathioprine | 3 | 1994 | 353 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1992 | 820 | 0.020 |
Why?
|
Pancreatectomy | 2 | 2006 | 804 | 0.020 |
Why?
|
Hypoglycemic Agents | 2 | 2008 | 2872 | 0.020 |
Why?
|
Receptors, CXCR3 | 1 | 2006 | 237 | 0.020 |
Why?
|
Ureter | 1 | 1987 | 375 | 0.020 |
Why?
|
Postoperative Complications | 3 | 2019 | 15295 | 0.020 |
Why?
|
Lymphocytes | 2 | 1984 | 2617 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 7181 | 0.020 |
Why?
|
Incidence | 3 | 2013 | 20947 | 0.020 |
Why?
|
Young Adult | 3 | 2016 | 56430 | 0.020 |
Why?
|
Chronic Disease | 4 | 2005 | 9146 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 1989 | 4933 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5751 | 0.020 |
Why?
|
Insulin Resistance | 2 | 2008 | 3864 | 0.010 |
Why?
|
Binding, Competitive | 2 | 1983 | 1157 | 0.010 |
Why?
|
Mastectomy | 2 | 1965 | 1793 | 0.010 |
Why?
|
Atrophy | 1 | 2008 | 1583 | 0.010 |
Why?
|
L-Selectin | 1 | 2004 | 213 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 2006 | 389 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2008 | 1850 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 1983 | 659 | 0.010 |
Why?
|
Biological Therapy | 1 | 2004 | 138 | 0.010 |
Why?
|
Length of Stay | 4 | 2003 | 6309 | 0.010 |
Why?
|
Postoperative Period | 1 | 1988 | 1842 | 0.010 |
Why?
|
Receptors, CCR2 | 1 | 2004 | 212 | 0.010 |
Why?
|
Axilla | 1 | 1965 | 595 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1989 | 2375 | 0.010 |
Why?
|
Kinetics | 1 | 1990 | 6473 | 0.010 |
Why?
|
Treatment Failure | 1 | 2008 | 2618 | 0.010 |
Why?
|
Mice, Nude | 2 | 1993 | 3689 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
Mice, Inbred AKR | 1 | 1981 | 107 | 0.010 |
Why?
|
Peptides | 2 | 2005 | 4409 | 0.010 |
Why?
|
Cortisone | 1 | 1982 | 89 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1992 | 6622 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1983 | 421 | 0.010 |
Why?
|
Adolescent | 6 | 2016 | 85781 | 0.010 |
Why?
|
Survival Rate | 2 | 1996 | 12788 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3271 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 40561 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 2274 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.010 |
Why?
|
Cell Fusion | 1 | 1981 | 297 | 0.010 |
Why?
|
Immune Sera | 1 | 2001 | 641 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1982 | 862 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 1988 | 984 | 0.010 |
Why?
|
Ribavirin | 1 | 2003 | 395 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2001 | 425 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
Fibrinogen | 1 | 2004 | 894 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2000 | 96 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1983 | 623 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1641 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2001 | 449 | 0.010 |
Why?
|
Obesity | 1 | 2003 | 12745 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 1992 | 3176 | 0.010 |
Why?
|
Glucagon | 1 | 2002 | 533 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1993 | 3386 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2505 | 0.010 |
Why?
|
Lymphopenia | 1 | 2002 | 285 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2007 | 3144 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2000 | 199 | 0.010 |
Why?
|
Cholesterol | 2 | 2004 | 2917 | 0.010 |
Why?
|
Gastrectomy | 2 | 1957 | 663 | 0.010 |
Why?
|
Splenectomy | 1 | 2001 | 395 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 2006 | 1598 | 0.010 |
Why?
|
Rats | 4 | 1996 | 24260 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 1965 | 1261 | 0.010 |
Why?
|
Gene Deletion | 1 | 2007 | 2751 | 0.010 |
Why?
|
ABO Blood-Group System | 1 | 2001 | 367 | 0.010 |
Why?
|
Lymphoproliferative Disorders | 1 | 2002 | 523 | 0.010 |
Why?
|
Organ Specificity | 1 | 2004 | 2008 | 0.010 |
Why?
|
Retreatment | 1 | 2000 | 610 | 0.010 |
Why?
|
Age Factors | 2 | 1994 | 18370 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4982 | 0.010 |
Why?
|
Interferon-alpha | 1 | 2003 | 895 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1981 | 795 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15165 | 0.010 |
Why?
|
Blood Proteins | 1 | 2003 | 1124 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2003 | 1157 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1965 | 2924 | 0.010 |
Why?
|
Prednisone | 2 | 1994 | 1574 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2001 | 2540 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6365 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5078 | 0.010 |
Why?
|
Constriction | 1 | 1996 | 181 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1996 | 378 | 0.010 |
Why?
|
Phenotype | 2 | 1993 | 16365 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1992 | 4253 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2749 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4217 | 0.010 |
Why?
|
Risk Factors | 3 | 2004 | 72290 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1996 | 448 | 0.010 |
Why?
|
Cell Separation | 1 | 2001 | 1751 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2006 | 18029 | 0.010 |
Why?
|
Thrombophlebitis | 1 | 1996 | 309 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2003 | 3206 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2004 | 2356 | 0.010 |
Why?
|
Medicare | 1 | 1992 | 6566 | 0.010 |
Why?
|
Monitoring, Immunologic | 1 | 1993 | 100 | 0.010 |
Why?
|
Pentamidine | 1 | 1992 | 45 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 440 | 0.010 |
Why?
|
H-Y Antigen | 1 | 1992 | 45 | 0.010 |
Why?
|
Adenoma, Bile Duct | 1 | 1992 | 30 | 0.010 |
Why?
|
Peptic Ulcer Perforation | 1 | 1952 | 24 | 0.010 |
Why?
|
Recurrence | 1 | 2004 | 8340 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23338 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11366 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1992 | 158 | 0.010 |
Why?
|
Chimera | 1 | 1993 | 485 | 0.010 |
Why?
|
Survival | 1 | 1992 | 163 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 1996 | 565 | 0.010 |
Why?
|
Biopsy | 1 | 2003 | 6756 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1992 | 249 | 0.010 |
Why?
|
Antibody Specificity | 2 | 1983 | 1095 | 0.010 |
Why?
|
Glucose | 1 | 2003 | 4397 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14722 | 0.010 |
Why?
|
Trans-Activators | 1 | 2000 | 2924 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 1998 | 2170 | 0.010 |
Why?
|
Blood Group Antigens | 1 | 1991 | 180 | 0.010 |
Why?
|
Quality of Life | 1 | 1991 | 12804 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 1992 | 6489 | 0.010 |
Why?
|
Aerosols | 1 | 1992 | 625 | 0.010 |
Why?
|
Child, Preschool | 1 | 1992 | 41006 | 0.010 |
Why?
|
Immunization | 1 | 1994 | 1256 | 0.010 |
Why?
|
Cryptococcus neoformans | 1 | 1989 | 119 | 0.010 |
Why?
|
Candida | 1 | 1989 | 172 | 0.010 |
Why?
|
Laparoscopy | 1 | 2001 | 2151 | 0.010 |
Why?
|
HLA Antigens | 1 | 1994 | 1381 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2006 | 19905 | 0.000 |
Why?
|
Drug Resistance | 1 | 1994 | 1609 | 0.000 |
Why?
|
Child | 2 | 1994 | 77709 | 0.000 |
Why?
|
Survival Analysis | 1 | 2000 | 10252 | 0.000 |
Why?
|
Mice, Inbred DBA | 1 | 1988 | 642 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7474 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1989 | 1681 | 0.000 |
Why?
|
Isoenzymes | 1 | 1991 | 1726 | 0.000 |
Why?
|
Renal Dialysis | 1 | 1996 | 1786 | 0.000 |
Why?
|
Ureteral Calculi | 1 | 1987 | 110 | 0.000 |
Why?
|
Methylprednisolone | 1 | 1987 | 387 | 0.000 |
Why?
|
Duodenum | 1 | 1989 | 483 | 0.000 |
Why?
|
Hepatectomy | 1 | 1989 | 550 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1993 | 2513 | 0.000 |
Why?
|
Costs and Cost Analysis | 1 | 1990 | 1681 | 0.000 |
Why?
|
Triglycerides | 1 | 1991 | 2454 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1996 | 2376 | 0.000 |
Why?
|
Stroke Volume | 1 | 1996 | 5007 | 0.000 |
Why?
|
Random Allocation | 1 | 1987 | 2429 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9648 | 0.000 |
Why?
|
Vascular Diseases | 1 | 1991 | 1161 | 0.000 |
Why?
|
Breast | 1 | 1951 | 1969 | 0.000 |
Why?
|
Immunoglobulin Light Chains | 1 | 1982 | 277 | 0.000 |
Why?
|
Fibroblasts | 1 | 1992 | 4161 | 0.000 |
Why?
|
Cross Reactions | 1 | 1983 | 841 | 0.000 |
Why?
|
Blood Pressure | 1 | 1996 | 8554 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1982 | 1454 | 0.000 |
Why?
|
Patient Readmission | 1 | 1994 | 3114 | 0.000 |
Why?
|
Administration, Oral | 1 | 1987 | 3913 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1958 | 9239 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1992 | 2214 | 0.000 |
Why?
|
Risk | 1 | 1992 | 9687 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1992 | 12026 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1965 | 20822 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1990 | 10943 | 0.000 |
Why?
|
Longevity | 1 | 1984 | 1070 | 0.000 |
Why?
|
Brain | 1 | 1982 | 26385 | 0.000 |
Why?
|
Pilot Projects | 1 | 1988 | 8324 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1990 | 9959 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1982 | 13815 | 0.000 |
Why?
|
Hypertension | 1 | 1990 | 8480 | 0.000 |
Why?
|